(S (NP (NNS Diabetes)) (VP (VBZ is) (NP (NP (DT a) (JJ major) (JJ public) (NN health) (NN problem)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States)))) (, ,) (S (VP (VBG affecting) (NP (QP (RB roughly) (CD 30) (CD million)) (NNS people))))) (. .))
(S (NP (NNS Diabetes) (NNS complications)) (, ,) (ADVP (IN along) (PP (IN with) (NP (NP (DT the) (JJ mental) (NN health) (NNS comorbidities)) (SBAR (WHNP (WDT that)) (S (ADVP (RB often)) (VP (VBP co-occur) (PP (IN with) (NP (PRP them))))))))) (, ,) (VP (VBP are) (NP (NP (JJ major) (NNS drivers)) (PP (IN of) (NP (NP (NP (JJ high) (NN healthcare) (NNS costs)) (, ,) (NP (JJ poor) (NNS outcomes)) (, ,) (CC and) (NP (VBD reduced) (NN treatment) (NN adherence))) (PP (IN in) (NP (NNS diabetes))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP evaluate) (PP (IN in) (NP (DT a) (JJ large) (JJ state-wide) (NN population))) (SBAR (IN whether) (S (NP (PRP we)) (VP (MD can) (VP (VB use) (NP (PRN (JJ artificial) (NN intelligence) (PRN (-LRB- -LRB-) (NNP AI) (-RRB- -RRB-))) (VBZ techniques)) (S (VP (S (VP (TO to) (VP (VB identify) (NP (NP (NNS clusters)) (PP (IN of) (NP (JJ patient) (NNS trajectories))) (PP (IN within) (NP (DT the) (JJR broader) (NNS diabetes) (NN population))))))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB create) (NP (NP (JJ cost-effective) (, ,) (JJ narrowly-focused) (NN case) (NN management) (NN intervention) (NNS strategies)) (SBAR (S (VP (TO to) (VP (VB reduce) (NP (NP (NN development)) (PP (IN of) (NP (NNS complications)))))))))))))))))))) (. .))
(S (NP (DT This) (NN approach)) (VP (VBD combined) (NP (NP (NNS data)) (PP (IN from) (: :) (NP (NP (CD 1) (-RRB- -RRB-) (NP (NNS claims))) (, ,) (NP (PRN (CD 2) (-RRB- -RRB-)) (NP (NN case) (NN management) (NNS notes))) (, ,) (CC and) (ADJP (CD 3) (-RRB- -RRB-) (NP (NP (JJ social) (NNS determinants)) (PP (IN of) (NP (NN health))))) (PP (IN from) (NP (NP (CD ~300,000) (JJ real) (NNS patients)) (PP (IN between) (NP (CD 2014) (CC and) (CD 2016))))))))) (. .))
(S (NP (PRP We)) (VP (VBD categorized) (NP (NNS complications)) (PP (IN as) (NP (NP (CD five) (NNS types)) (: :) (NP (NP (NN Cardiovascular)) (, ,) (NP (NNP Neuropathy)) (, ,) (NP (NNP Opthalmic)) (, ,) (NP (NNP Renal)) (, ,) (CC and) (ADJP (JJ Other)))))) (. .))
(S (NP (NN Modeling)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG combining) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN machine) (VBG learning) (NNS algorithms))) (, ,) (PP (VBG including) (NP (NP (VBN supervised) (NN classification)) (, ,) (NP (JJ unsupervised) (NN clustering)) (, ,) (NP (NP (JJ natural) (NN language) (NN processing)) (PP (IN of) (NP (JJ unstructured) (NN care) (NNS notes)))) (, ,) (CC and) (NP (NN feature) (NN engineering))))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP we)) (VP (MD can) (VP (VB predict) (NP (NP (NN development)) (PP (IN of) (NP (NNS diabetes) (NNS complications)))) (NP (NP (QP (RB roughly) (CD 83.5)) (NN %)) (PP (IN of) (NP (DT the) (NN time)))) (S (VP (VBG using) (NP (NP (NNS claims) (NNS data)) (CC or) (NP (NP (JJ social) (NNS determinants)) (PP (IN of) (NP (NN health) (NNS data)))))))))))) (. .))
(S (NP (PRP They)) (ADVP (RB also)) (VP (VBD showed) (SBAR (S (NP (PRP we)) (VP (MD can) (VP (VB reveal) (NP (NP (JJ meaningful) (NNS clusters)) (PP (IN in) (NP (DT the) (JJ patient) (NN population))) (VP (VBN related) (PP (TO to) (NP (NP (NNS complications)) (CC and) (NP (JJ mental) (NN health))))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN used) (PP (TO to) (NP (JJ cost-effective) (NN screening) (NN program))))))))) (, ,) (S (VP (VBG reducing) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS patients))) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN screened))))))) (RP down) (PP (IN by) (NP (CD 85) (NN %)))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ outlines) (NP (NP (NN creation)) (PP (IN of) (NP (NP (DT an) (NNP AI) (NN framework)) (SBAR (S (VP (TO to) (VP (VB develop) (NP (NP (NNS protocols)) (SBAR (S (VP (TO to) (VP (ADVP (JJR better)) (JJ address) (NP (NP (JJ mental) (NN health) (NNS comorbidities)) (SBAR (WHNP (WDT that)) (S (VP (VBP lead) (PP (TO to) (NP (NNS complications) (NN development))) (PP (IN in) (NP (DT the) (NNS diabetes) (NN population)))))))))))))))))))) (. .))
(S (NP (NP (JJ Future) (NN work))) (VP (VBZ is) (VP (VBN described) (SBAR (WHNP (IN that)) (S (VP (VBZ outlines) (NP (NP (NP (JJ potential) (NNS lines)) (PP (IN of) (NP (NN research)))) (CC and) (NP (NP (DT the) (NN need)) (PP (IN for) (S (VP (ADVP (JJR better)) (VBG addressing) (NP (NP (DT the) (JJ 'people) (NN side) ('' â€º)) (PP (IN of) (NP (DT the) (NN equation)))))))))))))) (. .))
